A phase II study of concurrent temozolomide and cis-retinoic acid with radiation for adult patients with newly diagnosed supratentorial glioblastoma
- 31 March 2005
- journal article
- research article
- Published by Elsevier in International Journal of Radiation Oncology*Biology*Physics
- Vol. 61 (5) , 1454-1459
- https://doi.org/10.1016/j.ijrobp.2004.08.023
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Plasma and Cerebrospinal Fluid Pharmacokinetics of Intravenous Temozolomide in Non-human PrimatesJournal of Neuro-Oncology, 2003
- Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trialsThe Lancet, 2002
- Promising Survival for Patients With Newly Diagnosed Glioblastoma Multiforme Treated With Concomitant Radiation Plus Temozolomide Followed by Adjuvant TemozolomideJournal of Clinical Oncology, 2002
- A rapid and systematic review of the effectiveness of temozolomide for the treatment of recurrent malignant gliomaBritish Journal of Cancer, 2002
- A phase II study of temozolomide vs. procarbazine in patients with glioblastoma multiforme at first relapseBritish Journal of Cancer, 2000
- Survival of human glioma cells treated with various combination of temozolomide and X-raysInternational Journal of Radiation Oncology*Biology*Physics, 2000
- Multicenter Phase II Trial of Temozolomide in Patients With Anaplastic Astrocytoma or Anaplastic Oligoastrocytoma at First RelapseJournal of Clinical Oncology, 1999
- In vitro evaluation of temozolomide combined with X-irradiationAnti-Cancer Drugs, 1997
- Meta-analysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adultsCancer, 1993
- An overview of published results from randomized studies of nitrosoureas in primary high grade malignant gliomaBritish Journal of Cancer, 1987